# Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

> **NCT06693791** · PHASE2 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 34 (estimated)

## Conditions studied

- Platelet Recovery After Umbilical Cord Blood Transplantation

## Interventions

- **DRUG:** Romiplostim N01

## Key facts

- **NCT ID:** NCT06693791
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693791, "Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06693791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*